Oral ARV-1801 Given in Combination With Intravenous Ceftazidime or Meropenem for Treatment of Melioidosis in Hospitalized Patients
Clinical trial NCT05105035 · COMPLETED
Trial details
- NCT number
- NCT05105035
- Sponsor
- Arrevus Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-14
- Primary completion
- 2023-10-10
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.